263 related articles for article (PubMed ID: 25806783)
1. Narrowband UV-B Phototherapy for Steroid-Refractory Sclerotic Chronic Cutaneous Graft-vs-Host Disease.
Sorenson E; McAndrew R; Patel V; Logan AC; Koo J; Levin E
JAMA Dermatol; 2015 Jun; 151(6):635-7. PubMed ID: 25806783
[TBL] [Abstract][Full Text] [Related]
2. UV treatment of chronic skin graft-versus-host disease--focus on UVA1 and extracorporeal photopheresis.
Greinix HT; Tanew A
Curr Probl Dermatol; 2012; 43():116-31. PubMed ID: 22377925
[TBL] [Abstract][Full Text] [Related]
3. Phototherapy for the treatment of cutaneous graft versus host disease.
Garbutcheon-Singh KB; Fernández-Peñas P
Australas J Dermatol; 2015 May; 56(2):93-9. PubMed ID: 25302552
[TBL] [Abstract][Full Text] [Related]
4. Narrowband ultraviolet B phototherapy in the treatment of cutaneous graft-versus-host disease in oncohaematological paediatric patients.
Brazzelli V; Grasso V; Muzio F; Moggio E; Zecca M; Locatelli F; Borroni G
Br J Dermatol; 2010 Feb; 162(2):404-9. PubMed ID: 19903177
[TBL] [Abstract][Full Text] [Related]
5. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
Olson KA; West K; McCarthy PL
Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567
[TBL] [Abstract][Full Text] [Related]
6. Narrowband UV-B phototherapy in the treatment of cutaneous graft versus host disease.
Grundmann-Kollmann M; Martin H; Ludwig R; Klein S; Boehncke WH; Hoelzer D; Kaufmann R; Podda M
Transplantation; 2002 Dec; 74(11):1631-4. PubMed ID: 12490799
[TBL] [Abstract][Full Text] [Related]
7. Psoralen plus ultraviolet-A-bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease.
Leiter U; Kaskel P; Krähn G; Gottlöber P; Bunjes D; Peter RU; Kerscher M
Photodermatol Photoimmunol Photomed; 2002 Aug; 18(4):183-90. PubMed ID: 12390673
[TBL] [Abstract][Full Text] [Related]
8. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin.
Wetzig T; Sticherling M; Simon JC; Hegenbart U; Niederwieser D; Al-Ali HK
Bone Marrow Transplant; 2005 Mar; 35(5):515-9. PubMed ID: 15665847
[TBL] [Abstract][Full Text] [Related]
9. Case of thymoma-associated cutaneous graft-versus-host disease-like disease successfully improved by narrowband ultraviolet B phototherapy.
Yatsuzuka K; Tohyama M; Oda F; Hashimoto T; Sayama K
J Dermatol; 2018 Apr; 45(4):479-482. PubMed ID: 29215146
[TBL] [Abstract][Full Text] [Related]
10. The role of phototherapy in cutaneous chronic graft-vs-host disease: a retrospective study and review of the literature.
Ballester-Sánchez R; Navarro-Mira MÁ; de Unamuno-Bustos B; Pujol-Marco C; Sanz-Caballer J; Botella-Estrada R
Actas Dermosifiliogr; 2015 Oct; 106(8):651-7. PubMed ID: 26032871
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal Photopheresis: An Efficacious and Well-Tolerated Treatment for Cutaneous and Oral Mucosal Chronic Graft-versus-Host Disease.
Richet C; Huynh A; Dimeglio C; Borel C; Lepage B; Boulinguez S; Marguery MC; Paul C; Bulai Livideanu C
Dermatology; 2018; 234(1-2):23-30. PubMed ID: 29788024
[TBL] [Abstract][Full Text] [Related]
12. Peritransplant use of ultraviolet-B irradiation (UV-B) therapy is detrimental to allogeneic stem cell transplantation outcome.
Yüksel M; Baron E; Camouse M; Cooper BW; Lazarus HM; Gerson SL; Laughlin MJ; Cooper KD; Gilliam A; Fu P; Stevens S; Koç ON
Biol Blood Marrow Transplant; 2006 Jun; 12(6):665-71. PubMed ID: 16737940
[TBL] [Abstract][Full Text] [Related]
13. Annular plaques: An unusual manifestation of graft-versus-host disease.
Alexander LJ; Paravar T; Duvic M; Prieto V; Hymes SR
Dermatol Online J; 2012 Jun; 18(6):4. PubMed ID: 22747928
[TBL] [Abstract][Full Text] [Related]
14. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
[TBL] [Abstract][Full Text] [Related]
15. Steroid refractory psoriasiform cutaneous graft versus host disease successfully treated by extracorporeal photopheresis: a case report.
Sirinoglu Demiriz I; Tekgunduz E; Tetik A; Kayikci O; Altuntas F
Transfus Apher Sci; 2013 Feb; 48(1):109-11. PubMed ID: 23017807
[TBL] [Abstract][Full Text] [Related]
16. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
[TBL] [Abstract][Full Text] [Related]
17. Partial reconstitution of cutaneous microvessels in long-term survivors after allogeneic bone marrow transplantation.
Haeusermann P; Kump E; Rovó A; Tichelli A; Itin P; Gratwohl A; Biedermann BC
Dermatology; 2009; 219(1):32-41. PubMed ID: 19407437
[TBL] [Abstract][Full Text] [Related]
18. Pediatric Cutaneous Graft Versus Host Disease: A Review.
Shi CR; Huang JT; Nambudiri VE
Curr Pediatr Rev; 2017; 13(2):100-110. PubMed ID: 28641548
[TBL] [Abstract][Full Text] [Related]
19. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD).
Ayyildiz E; Arslan O; Topçuoğlu P; Arat M; Dalva K; Soydan EA; Tol M; Ilhan O
Transfus Apher Sci; 2007 Feb; 36(1):79-85. PubMed ID: 17234454
[TBL] [Abstract][Full Text] [Related]
20. Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.
Baird K; Comis LE; Joe GO; Steinberg SM; Hakim FT; Rose JJ; Mitchell SA; Pavletic SZ; Figg WD; Yao L; Flanders KC; Takebe N; Sarantopoulos S; Booher S; Cowen EW
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1083-90. PubMed ID: 25771402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
